Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: An analysis of DAPA‐HF
P Dewan, KF Docherty, O Bengtsson… - European Journal of …, 2021 - Wiley Online Library
Aims Chronic obstructive pulmonary disease (COPD) is an important comorbidity in heart
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
Effects of dapagliflozin in heart failure with reduced ejection fraction, and chronic obstructive pulmonary disease: an analysis of DAPA-HF
P Dewan, KF Docherty, O Bengtsson… - European Journal of …, 2021 - research.regionh.dk
AIMS: Chronic obstructive pulmonary disease (COPD) is an important comorbidity in heart
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
[HTML][HTML] Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF
P Dewan, KF Docherty, O Bengtsson… - European Journal of …, 2021 - ncbi.nlm.nih.gov
Aims Chronic obstructive pulmonary disease (COPD) is an important comorbidity in heart
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF.
P Dewan, KF Docherty, O Bengtsson… - European Journal of …, 2021 - europepmc.org
Aims Chronic obstructive pulmonary disease (COPD) is an important comorbidity in heart
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
Effects of dapagliflozin in heart failure with reduced ejection fraction, and chronic obstructive pulmonary disease: an analysis of DAPA-HF
P Dewan, KF Docherty, O Bengtsson… - European Journal of …, 2021 - eprints.gla.ac.uk
Aims: Chronic obstructive pulmonary disease (COPD) is an important comorbidity in HFrEF,
associated with worse outcomes and often suboptimal treatment because of under …
associated with worse outcomes and often suboptimal treatment because of under …
Effects of dapagliflozin in heart failure with reduced ejection fraction, and chronic obstructive pulmonary disease: an analysis of DAPA-HF
P Dewan, KF Docherty, O Bengtsson… - European Journal of …, 2021 - research.rug.nl
AIMS: Chronic obstructive pulmonary disease (COPD) is an important comorbidity in HFrEF,
associated with worse outcomes and often suboptimal treatment because of under …
associated with worse outcomes and often suboptimal treatment because of under …
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF
P Dewan, KF Docherty, O Bengtsson, RA de Boer… - 2021 - pubmed.ncbi.nlm.nih.gov
Aims Chronic obstructive pulmonary disease (COPD) is an important comorbidity in heart
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF
P Dewan, KF Docherty, O Bengtsson… - … Journal of Heart …, 2021 - publicum.umed.lodz.pl
Aims: Chronic obstructive pulmonary disease (COPD) is an important comorbidity in heart
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF
P Dewan, KF Docherty, O Bengtsson… - … Journal of Heart …, 2021 - publicum.umed.lodz.pl
Aims: Chronic obstructive pulmonary disease (COPD) is an important comorbidity in heart
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF.
P Dewan, KF Docherty, O Bengtsson… - European Journal of …, 2021 - europepmc.org
Aims Chronic obstructive pulmonary disease (COPD) is an important comorbidity in heart
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …
failure (HF) with reduced ejection fraction (HFrEF), associated with worse outcomes and …